PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
50.49%
Some net income increase while VET is negative at -70.54%. John Neff would see a short-term edge over the struggling competitor.
-21.59%
Both reduce yoy D&A, with VET at -27.57%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
35.94%
Lower deferred tax growth vs. VET's 157.82%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
80.00%
SBC growth well above VET's 28.38%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-42.00%
Negative yoy working capital usage while VET is 756.10%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-42.00%
Negative yoy usage while VET is 756.10%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
256.67%
Well above VET's 11.77%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-1.10%
Negative yoy CFO while VET is 34.88%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
40.80%
Some CapEx rise while VET is negative at -17.04%. John Neff would see competitor possibly building capacity while we hold back expansions.
668.69%
Acquisition growth of 668.69% while VET is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-10.59%
Negative yoy purchasing while VET stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-40.80%
We reduce yoy sales while VET is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
40.59%
We have some outflow growth while VET is negative at -17.03%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
153.68%
We have mild expansions while VET is negative at -17.23%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-4166.67%
We cut debt repayment yoy while VET is 26.83%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.